Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Alaa El-Gindy is active.

Publication


Featured researches published by Alaa El-Gindy.


Journal of Pharmaceutical and Biomedical Analysis | 2003

Spectrophotometric and chromatographic determination of rabeprazole in presence of its degradation products

Alaa El-Gindy; Fawzy El-Yazby; Moustafa M Maher

Three methods were presented for the determination of rabeprazole (RA) in presence of its degradation products. The first method was based on high performance liquid chromatographic (HPLC) separation of RA from its degradation products on a reversed phase, ODS column using a mobile phase of methanol-water (70:30, v/v) and UV detection at 284 nm. The second method was based on HPTLC separation followed by densitometric measurement of the spots at 284 nm. The separation was carried out on Merck HPTLC sheets of silica gel 60 F 254, using acetone-toluene-methanol (9:9:0.6 v/v) as mobile phase. The third method depends on first derivative of the ratio spectra (1DD) by measurement of the amplitudes at 310.2 nm. Moreover, the proposed HPLC method was utilized to investigate the kinetics of the oxidative and photo degradation processes. The pH-rate profile of degradation of RA in Britton-Robinson buffer solutions within the pH range 3-11 was studied. In addition, the activation energy of RA degradation was calculated in Britton-Robinson buffer solution pH 7.


Journal of Pharmaceutical and Biomedical Analysis | 2001

Application of LC and HPTLC-densitometry for the simultaneous determination of benazepril hydrochloride and hydrochlorothiazide

Alaa El-Gindy; Ahmed Ashour; Laila Abdel-Fattah; Marwan M Shabana

Two methods are described for the simultaneous determination of benazepril HCl and hydrochlorothiazide in binary mixture. The first method was based on HPTLC separation of the two drugs followed by densitometric measurements of their spots at 238 and 275 nm for benazepril HCl and hydrochlorothiazide, respectively. The separation was carried out on Merck HPTLC aluminum sheets of silica gel 60 F(254,) using ethyl acetate-methanol-chloroform (10:3:2 v/v) as mobile phase. Second order polynomial equation was used for the regression line in the range 2-20 and 2.5-25 microg/spot for benazepril HCl and hydrochlorothiazide, respectively. The second method was based on HPLC separation of the two drugs on reversed phase, ODS column at ambient temperature using a mobile phase consisting of acetonitrile and water (35:65 v/v) and adjusting to pH 3.3 with acetic acid. Quantitation was achieved with UV detection at 240 nm based on peak area with linear calibration curves at concentration ranges 10-60 and 12.5-75 microg ml(-1) for benazepril HCl and hydrochlorothiazide, respectively. The two proposed methods were successfully applied to the determination of both drugs in laboratory prepared mixtures and in commercial tablets. No chromatographic interference from the tablets excipients was found.


Journal of Pharmaceutical and Biomedical Analysis | 2001

Spectrophotometric and HPTLC-densitometric determination of lisinopril and hydrochlorothiazide in binary mixtures.

Alaa El-Gindy; Ahmed Ashour; Laila Abdel-Fattah; Marwan M Shabana

Different spectrophotometric and HPTLC-densitometric methods are presented for the simultaneous determination of lisinopril and hydrochlorothiazide in pharmaceutical tablets. The spectrophotometric methods include third derivative (3D) ultraviolet spectrophotometry with zero crossing measurement at 217.4 and 233.4 nm, second derivative of the ratio spectra with measurement at 214.3 and 228.0 nm; both classical least squares and principal component regression were applied to the UV absorption and first derivative spectra of the mixture. The HPTLC method was based on separation of both drugs followed by densitometric measurements of their spots at 210 and 275 nm for lisinopril and hydrochlorothiazide, respectively. The separation was carried out on Merck HPTLC aluminum plates of silica gel 60 F254, using chloroform-ethylacetate-acetic acid (10:3:2 by vol.) as mobile phase. The linear and second order polynomial were used for the regression equation of lisinopril and hydrochlorothiazide, respectively.


Journal of Pharmaceutical and Biomedical Analysis | 2001

Spectrophotometric determination of trifluoperazine HCl and isopropamide iodide in binary mixture using second derivative and second derivative of the ratio spectra methods

Alaa El-Gindy; Badr A. El-Zeany; Tamer Awad; Marwan M Shabana

Two methods are presented for the simultaneous determination of trifluoperazine hydrochloride and isopropamide iodide in binary mixture. The first method depends on second derivative ((2)D) ultraviolet spectrophotometry, with zero crossing and peak to base measurement. The second derivative amplitudes at 270.4 and 230.2 nm were selected for the assay of trifluoperazine hydrochloride and isopropamide iodide, respectively. The second method depends on second derivative of the ratio spectra by division of the absorption spectrum of the binary mixture by a normalized spectrum of one of the components and then calculating the second derivative of the ratio spectrum. The second derivative of the ratio amplitudes at 257 and 228 nm were selected for the determination of trifluoperazine hydrochloride and isopropamide iodide, respectively. The two proposed methods were successfully applied to the determination of the two drugs in laboratory prepared mixtures and in commercial tablets.


Journal of Pharmaceutical and Biomedical Analysis | 2001

Spectrophotometric determination of benazepril hydrochloride and hydrochlorothiazide in binary mixture using second derivative, second derivative of the ratio spectra and chemometric methods

Alaa El-Gindy; Ahmed Ashour; Laila Abdel-Fattah; Marwan M Shabana

Different spectrophotometric methods are presented for the simultaneous determination of benazepril hydrochloride and hydrochlorothiazide in pharmaceutical tablets. The first method depends on second derivative (2D) ultraviolet spectrophotometry, with zero crossing and peak to base measurement. The second derivative amplitudes at 214.8 and 227.4 nm were selected for the assay of benazepril hydrochloride and hydrochlorothiazide, respectively. The second method depends on second derivative of the ratio spectra by measurement of the amplitudes at 241.2 and 273.2 nm for benazepril hydrochloride and hydrochlorothiazide, respectively. Chemometric methods, classical least squares and principal component regression, were applied to analyze the mixture. Both the chemometric methods were applied to the zero and first order spectra of the mixture. The proposed methods were successfully applied for the determination of the two drugs in laboratory prepared mixtures and in commercial tablets.


Journal of Pharmaceutical and Biomedical Analysis | 2000

First-derivative spectrophotometric and LC determination of cefuroxime and cefadroxil in urine

Alaa El-Gindy; Abdel Fattah M. El Walily; Mohamed F. Bedair

Two methods are presented for the determination of cefuroxime and cefadroxil in human urine using first (1D) derivative spectrophotometry and high-performance liquid chromatography. Cefuroxime and cefadroxil were determined by measurement of their first-derivative amplitude in 0.1 N sodium hydroxide at 292.5 and 267.3 nm, respectively in the concentration range of 2-10 microg ml(-1) for each drug. The HPLC method depends upon using a LiChrospher 100 RP-18 (5 microm) column at ambient temperature for cefuroxime and 35 degrees C for cefadroxil with mobile phases consisting of water-acetonitrile-acetic acid (85:15:0.1 v/v) at a flow rate of 1.5 ml min(-1) for cefuroxime; and 0.02 M potassium dihydrogen phosphate-acetonitrile (95:5 v/v) containing 0.003% (w/v) hexanesulphonic acid sodium salt and adjusted to apparent pH 3 with phosphoric acid at a flow rate of 2 ml min(-1) for cefadroxil. Quantitation was achieved with UV detection at 275 and 260 nm for cefuroxime and cefadroxil, respectively, based on peak area with linear calibration curves at the concentration ranges of 2-10 microg ml(-1) for cefuroxime and 5-20 microg ml(-1) for cefadroxil. The proposed methods were applied to the determination of dissolution rate for tablets and capsules containing each drug. The urinary excretion patterns as the cumulative amounts excreted have been calculated for each drug using the proposed methods.


Journal of Pharmaceutical and Biomedical Analysis | 2001

Spectrophotometric, septrofluorimetric and LC determination of lisinopril.

Alaa El-Gindy; Ahmed Ashour; Laila Abdel-Fattah; Marwan M Shabana

Three methods are described for the determination of lisinopril in the pharmaceutical tablets. The spectrophotometric method depends on the reaction of the lisinopril with sodium hypochlorite and phenyl hydrazine to form a condensation product measured at 362 nm. The spectrophotometric method was extended to develop a stability indicating method. The spectrofluorimetric method depends on reaction of the lisinopril with o-phthalaldehyde in the presence of 2-mercaptoethanol in borate buffer pH 9.5. The fluorescence of the reaction product was measured upon excitation at a maximum of 340 nm with emission wavelength at 455 nm. The HPLC method depends on using Hypersil silica column with a mobile phase consisting of methanol-water-triethylamine (50:50:0.1 v/v) and the pH was adjusted to 2.6 with 0.1 N perchloric acid. Quantitation was achieved with UV detection at 210 nm based on peak area.


Journal of Pharmaceutical and Biomedical Analysis | 2001

First derivative spectrophotometric, TLC-densitometric, and HPLC determination of acebutolol HCL in presence of its acid-induced degradation product.

Alaa El-Gindy; Ahmed Ashour; Laila Abdel-Fattah; Marwan M Shabana

Three methods are presented for the determination of acebutolol HCl in presence of its acid-induced degradation product. The first method was based on measurement of the first derivative amplitude of acebutolol HCl at 266.6 nm. The second method was based on separation of acebutolol HCl from its acid-induced degradation product followed by densitometric measurement of the spots at 230 nm. The separation was carried out on silica gel 60 F254, using ethanol-glacial acetic acid (4:1, v/v) as mobile phase. Second order polynomial equation was used for the regression line. The third method was based on high performance liquid chromatographic (HPLC) separation of acebutolol HCl from its acid-induced degradation product on a reversed phase, ODS column using a mobile phase of methanol-water (55:45, v/v) with UV detection at 240 nm. The first derivative spectrophotometric method was utilized to investigate the kinetics of the acid degradation process at different temperatures.


Journal of Pharmaceutical and Biomedical Analysis | 2002

Derivative spectrophotometric, thin layer chromatographic-densitometric and high performance liquid chromatographic determination of trifluoperazine hydrochloride in presence of its hydrogen peroxide induced-degradation product

Alaa El-Gindy; Badr A. El-Zeany; Tamer Awad; Marwan M Shabana

Three methods are presented for the determination of trifluoperazine HCl in presence of its hydrogen peroxide induced degradation product. The first method was based on measurement of first (1D) and second (2D) derivative amplitudes of trifluoperazine HCl in 0.1 N hydrochloric acid at the zero crossing point of its sulfoxide derivative, main degradation product, (at 268.4 and 262.5 nm for 1D and 2D, respectively). The second method was based on the separation of trifluoperazine HCl from its sulfoxide derivative followed by densitometric measurement of the intact drug spot at 255 nm. The separation was carried out on Merck aluminum sheet of silica gel 60 F(254), using chloroform-methanol (7:3 v/v) as mobile phase. The third method was based on high performance liquid chromatographic separation of trifluoperazine HCl from its sulfoxide derivative on reversed phase, ODS column, using a mobile phase of acetonitrile-phosphate buffer pH 4.2 (60:40 v/v) at ambient temperature. Quantitation was achieved with UV detection at 255 nm based on peak area. The first derivative spectrophotometric method was utilized to investigate the kinetics of the hydrogen peroxide degradation process at different temperatures. The apparent pseudo first-order rate constant, half life and activation energy were calculated.


Journal of Pharmaceutical and Biomedical Analysis | 2003

Spectrophotometric and LC determination of two binary mixtures containing pyridoxine hydrochloride

Alaa El-Gindy

Several methods are developed for the determination of two binary mixtures containing pyridoxine HCl together with either metoclopramide HCl (mixture 1) or meclozine HCl (mixture 2). The resolution of binary mixture of pyridoxine HCl and metoclopramide HCl has been accomplished by using partial least squares (PLS-1) and principal component regression (PCR) applied to zero and first order UV spectra of the mixture, respectively. In addition HPLC method depending on using RP18 column with a mobile phase consisting of acetonitrile-water (30:70, v/v, pH 3.2) with UV detection at 305 nm was developed. In mixture 2, the simultaneous determination of pyridoxine HCl and meclozine HCl was carried out by using graphical (second derivative of the ratio spectra) and numerical spectrophotometric methods (principal component regression and partial least squares, PLS-1 and PLS-2, applied to the zero order UV spectra of the mixture). The proposed methods were successfully applied for the determination of the two binary combinations in synthetic mixtures and in commercial tablets and syrup containing several light absorbing excipients.

Collaboration


Dive into the Alaa El-Gindy's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge